CHICAGO: In a major development for oral health worldwide, the American Dental Association (ADA) has reaffirmed that comprehensive clinical examinations remain the cornerstone of early oral cancer detection, cautioning against overreliance on cytology adjuncts except in very specific cases.
Published in the March issue of The Journal of the American Dental Association, the new living guideline—the first of its kind for oral squamous cell carcinoma and potentially malignant disorders—clarifies that punch or scalpel biopsy followed by histopathology is still the most reliable method to achieve a definitive diagnosis.
“Screening and early detection of oral potentially malignant disorders and oral cavity cancer can improve patient outcomes,” said Dr. Mark Lingen, D.D.S., Ph.D., professor of pathology at University of Chicago Medicine and former ADA Council on Scientific Affairs member.
Living guidelines: a new era in evidence-based dental care
The ADA’s Living Guideline Program, established in 2025, ensures that dental professionals receive up-to-date, evidence-informed recommendations as new research emerges. Unlike traditional static guidelines, these “living” recommendations are updated frequently, keeping clinicians equipped with the latest scientific insights.
Cytology adjuncts: limited, cautious use
The guideline advises against using cytology brushes to determine biopsy needs or to screen asymptomatic adults, citing risks of false positives and insufficient supporting evidence. They may, however, serve as a temporary triage tool when biopsy is not feasible, to help inform—but not replace—clinical decision-making.
“Based on current evidence, cytology should not replace biopsy for diagnosing oral potentially malignant disorders or oral cavity cancer,” emphasized Dr. Lingen. “In select cases where biopsy isn’t possible, cytology may help guide the next steps, but it cannot rule out disease.”
Good practice statement: vigilance is critical
Even when cytology returns a negative result, clinicians are advised to monitor persistent or progressive mucosal abnormalities closely and proceed with biopsy or referral to a specialist to avoid delayed diagnosis.
Guideline development: rigor meets collaboration
The recommendations were shaped by a multidisciplinary expert panel led by Dr. Lingen, with methodology support from the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine. Public comments from oral health professionals also contributed, ensuring the guideline addresses real-world clinical concerns.
Looking ahead
Future guideline updates will address additional tools such as vital staining adjuncts, light-based technologies, and salivary tests, providing dental professionals with the latest strategies to enhance early oral cancer detection.
Early detection saves lives. Every oral exam counts.
Stay updated, stay ahead!
CLICK HERE TO FOLLOW Dental News Pakistan on WhatsApp now to never miss an update!